Role of P-glycoprotein inhibitors in ceramide-based therapeutics for treatment of cancer
SAF Morad, TS Davis, MR MacDougall, SF Tan… - Biochemical …, 2017 - Elsevier
The anticancer properties of ceramide, a sphingolipid with potent tumor-suppressor
properties, can be dampened via glycosylation, notably in multidrug resistance wherein …
properties, can be dampened via glycosylation, notably in multidrug resistance wherein …
Taxol-induced ceramide generation and apoptosis in human breast cancer cells
AG Charles, TY Han, YY Liu, N Hansen… - Cancer chemotherapy …, 2001 - Springer
Purpose: Taxol has emerged as a valuable antimitotic chemotherapeutic agent, particularly
in advanced breast and ovarian cancers. Although much is known about cytotoxic …
in advanced breast and ovarian cancers. Although much is known about cytotoxic …
[HTML][HTML] By activating Fas/ceramide synthase 6/p38 kinase in lipid rafts, stichoposide D inhibits growth of leukemia xenografts
SH Yun, ES Park, SW Shin, MH Ju, JY Han, JS Jeong… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Stichoposide D (STD) is a marine triterpene glycoside isolated from sea cucumbers. We
examined the molecular mechanisms underlying the antitumor activity of STD in human …
examined the molecular mechanisms underlying the antitumor activity of STD in human …
3-Ketone-4, 6-diene ceramide analogs exclusively induce apoptosis in chemo-resistant cancer cells
AP Ponnapakam, J Liu, KN Bhinge, BA Drew… - Bioorganic & medicinal …, 2014 - Elsevier
Multidrug-resistance is a major cause of cancer chemotherapy failure in clinical treatment.
Evidence shows that multidrug-resistant cancer cells are as sensitive as corresponding …
Evidence shows that multidrug-resistant cancer cells are as sensitive as corresponding …
Novel ceramide analogs as potential chemotherapeutic agents in breast cancer
AP Struckhoff, R Bittman, ME Burow, S Clejan… - … of Pharmacology and …, 2004 - ASPET
Recent evidence suggests a role for aberrant ceramide levels in the pathogenesis of cancer
and chemoresistance and indicates that manipulation of tumor ceramide levels may be a …
and chemoresistance and indicates that manipulation of tumor ceramide levels may be a …
Ceramide-induced formation of ROS and ATP depletion trigger necrosis in lymphoid cells
In lymphocytes, Fas activation leads to both apoptosis and necrosis, whereby the latter form
of cell death is linked to delayed production of endogenous ceramide and is mimicked by …
of cell death is linked to delayed production of endogenous ceramide and is mimicked by …
Ceramide synthesis and metabolism as a target for cancer therapy
CP Reynolds, BJ Maurer, RN Kolesnick - Cancer letters, 2004 - Elsevier
Sphingolipids, which include ceramides and sphingosine, are essential structural
components of cell membranes that also have messenger functions that regulate the …
components of cell membranes that also have messenger functions that regulate the …
The novel synthetic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) causes apoptosis in acute promyelocytic leukemia cells through …
L Mologni, I Ponzanelli, F Bresciani… - Blood, The Journal …, 1999 - ashpublications.org
Abstract The synthetic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic
acid (CD437), which was originally developed as an retinoic acid receptor (RAR)-γ agonist …
acid (CD437), which was originally developed as an retinoic acid receptor (RAR)-γ agonist …
Knockdown of lecithin retinol acyltransferase increases all‐trans retinoic acid levels and restores retinoid sensitivity in malignant melanoma cells
PM Amann, K Czaja, AV Bazhin, R Rühl… - Experimental …, 2014 - Wiley Online Library
Retinoids such as all‐trans retinoic acid (ATRA) influence cell growth, differentiation and
apoptosis and may play decisive roles in tumor development and progression. An essential …
apoptosis and may play decisive roles in tumor development and progression. An essential …
[HTML][HTML] Engraftment of human primary acute myeloid leukemia defined by integrated genetic profiling in NOD/SCID/IL2rγnull mice for preclinical ceramide-based …
BM Barth, NR Keasey, X Wang… - Journal of leukemia …, 2014 - ncbi.nlm.nih.gov
Abstract Acute Myeloid Leukemia (AML) is a highly heterogeneous and poor prognosis
disease with few available therapeutic options. Novel advances are urgently needed …
disease with few available therapeutic options. Novel advances are urgently needed …